DEVA.E.IS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: January 20, 2026
Report Source: 2025 3rd Quarter Report
D
Deva Holding AS. Stock Analysis DEVA.E.IS
Deva Holding AS engages in the production and marketing of human pharmaceuticals and raw materials. The firm has four production facilities in Turkey. Its production facilities include the Tokapi, Cerezkoy I, Cerezkoy II and Kartepe production plants. The Company’s product portfolio comprises 73 drugs, which are available on the market in 177 various forms. The company offers products, such as Azitro, Alemax, Cefax, Inhibace, Imatis, Hydrea, Kardozin, Kristapen, Magcar, Magnesie Calcinee, Nostil, Oceral, Remidon, Prolixin and Quet, among others. The firm has two subsidiaries, namely Vetaa Veteriner ve Tarim Ilaclari A.S. and Deva Holding NZ Ltd.
Read More Deva Holding AS (DEVA.E.IS) Chart
Key Statistics of Deva Holding AS (DEVA.E.IS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
TRY68.45Volume
738.42KP/E Ratio (TTM)
-52 Week Range
Market Cap
12.90BAvg. Volume
825.94KDividend Yield
3.38%Financial Metrics & Statements of Deva Holding AS (DEVA.E.IS)
FAQ's for Deva Holding AS (DEVA.E.IS)
- According to Musaffa’s Shariah screening methodology, Deva Holding AS (DEVA.E.IS) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.